Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
33700 Results Found
340B Advocacy Alliance Bulletin: Register for Monday, Feb. 22, 340B Alliance Call to Hear Legislative and Legal Updates
The AHA 340B Advocacy Alliance Feb. 22 at 3 p.m. ET will provide an update on the many legal cases and issues surrounding the 340B Drug Pricing Program.
AHA Concerns and Comments Re: CMS—10765: Agency Information Collection Activities: Proposed Collection
AHA asks the CMS to withdraw its proposed IRF review choice demonstration.
Case Study: Advancing Rural Telehealth and Addressing Its Challenges
The telehealth program at a small Texas hospital serves as one example of how trustees who closely interacted with administrators helped to lead the hospital’s timely use of telehealth during the C
Market Insights: AI’s Impact on Health Care
Emerging Artificial intelligence (AI) technologies can help organizations create more value for their patients and communities by converting time-consuming, labor-intensive and often inefficient tasks and functions into actionable information to produce better outcomes.
2020 COVID-19 Resources for Rural Hospitals
CARES Act: Provisions to Help Rural Hospitals
The Coronavirus Aid, Reli
Special enrollment period for Marketplace health coverage starts Monday
The Centers for Medicare & Medicaid Services launched a broadcast, radio and digital campaign to advertise to uninsured and other Americans the new special enrollment period available Feb. 15 through May 15 at the federally facilitated marketplace.
AHA #HealthCareInnovation blog: ‘Compassion tech’ and health innovation
AHA Center for Health Innovation Chief Operating Officer Andy Shin sees a new focus at the intersection of technology and the caregiver-patient relationship: compassion tech. In this week’s blog, Shin describes compassion tech and its promising potential for health care.
AHA blog: PhRMA report misleads on drug costs
Instead of attacking hospitals and health systems caring for patients during the COVID-19 pandemic, PhRMA should instead focus on lowering the costs of drugs for Americans, writes AHA Executive Vice President Tom Nickels.
Agencies purchase 200M more vaccine doses
The departments of Health and Human Services and Defense ordered 200 million more doses of COVID-19 vaccines authorized for emergency use, half from Pfizer for $2 billion and the rest from Moderna for about $1.7 billion.